Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New cat virus could reveal insights about hepatitis B
Until now, it was not known that companion animals could contract HBV.

Discovery first step in developing vaccine to prevent infection

Scientists in Australia have discovered hepadnavirus (HBV) in an immunocompromised feline.

Until now, it was not known that companion animals could contract HBV - a virus that is in the same family as hepatitis B. Researchers said that the importance of the finding could not be overstated.

“Finding a new virus responsible for disease is the first step in developing a vaccine to prevent infection,” said Dr Kelly Diehl of the Morris Animal Foundation, which funded the research. “It’s especially exciting if the vaccine could prevent a future cancer from developing in immunocompromised or other vulnerable cats.”

The virus was first discovered by a team at the University of Sydney in an immunodeficient cat that had died of lymphoma. After identifying the virus, the researchers tested stored blood samples from adult cats.

To their surprise, they found evidence of hepadnavirus infection in the samples.

“This is a very exciting discovery,” said corresponding author Julia Beatty, Professor of Feline Medicine at Sydney. “Apart from its relevance for feline health, this discovery helps us understand how hepatitis viruses – which can be deadly – are evolving in all species."

The study, published in the journal Viruses, notes that the discovery presents no risk to humans or other pets.

 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.